STAGE IIIA LUNG CANCER AJCC V8
Clinical trials for STAGE IIIA LUNG CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIIA LUNG CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IIIA LUNG CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Lung cancer combo shows promise but study cut short
Disease control TerminatedThis study tested whether adding an immunotherapy drug (bintrafusp alfa) to standard chemotherapy (docetaxel) helps people with advanced non-small cell lung cancer whose disease got worse after prior treatment. Only 10 people enrolled before the study was stopped early. The goal …
Matched conditions: STAGE IIIA LUNG CANCER AJCC V8
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 26, 2026 04:23 UTC
-
Experimental cocktail aims to reboot immune attack on tough cancers
Disease control TerminatedThis early-phase study tested a drug called plinabulin combined with radiation and immunotherapy in 19 people with advanced cancers (like lung, bladder, or melanoma) that had stopped responding to standard immunotherapy. The goal was to see if the combination was safe and could s…
Matched conditions: STAGE IIIA LUNG CANCER AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 04:15 UTC
-
Experimental cancer combo trial halted early
Disease control TerminatedThis study tested a combination of two immunotherapy drugs (BMS-986218 and nivolumab) plus precise radiation for people with advanced solid tumors that had spread. The goal was to see if this approach could help control the cancer and check for side effects. Only 13 people took p…
Matched conditions: STAGE IIIA LUNG CANCER AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 22, 2026 13:54 UTC